Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a ...
To get to the bottom of the matter, the researchers analyzed data from 457 adults, 206 of whom reported they had ADHD symptoms. The test subjects were asked to collect ... may have been vital for the ...
Explore how ADHD impacts memory and what this means for daily life. Learn if ADHD can cause memory loss, the science behind it, and practical tips to improve focus and recall. Ideal for those with ...
This partnership helps address the area's critical shortage of care options for ADHD management among children and adults with ADHD symptoms. Qbtech's FDA-cleared objective testing solutions support ...